KeyBanc’s Positive View on STERIS (STE) Driven by MedTech Momentum
STERIS plc (NYSE:STE) is one of the best defensive stocks to invest in according to analysts.
Steris Plc (STE)
Market is closed
Sector: Healthcare
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Generation Investment Management David Blood And Al Gore | 3,170,717 | $761,669,640 | -6% | 4.84% |
| 2. | Orbis Investment Management William B. Gray | 2,100,099 | $504,485,782 | +37% | 2.45% |
| 3. | Select Equity Group Robert Joseph Caruso | 2,052,433 | $493,035,455 | -8% | 2.07% |
| 4. | Point72 Asset Management Steve Cohen | 423,327 | $101,691,666 | -8% | 0.2% |
| 5. | AQR Capital Management Cliff Asness | 424,647 | $101,681,854 | +131% | 0.08% |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $241.82 | 159 | $38,449.38 | 51,096 | 2025-10-06 | Filing | |
| $249.24 | 3,204 | $798,564.96 | 7,221 | 2025-08-20 | Filing | |
| $241.96 | 4,110 | $994,455.60 | 22,361 | 2025-08-11 | Filing | |
| $241.56 | 3,495 | $844,252.20 | 705 | 2025-08-11 | Filing | |
| $241.73 | 7,900 | $1,909,667.00 | 5,994 | 2025-08-11 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 330,907 | $81,879,628 | 0.11% | |
| 2. | 324,264 | $80,235,884 | 0.59% | |
| 3. | 256,578 | $63,487,660 | 0.06% | |
| 4. | 184,511 | $45,655,807 | 0.95% | |
| 5. | 133,224 | $32,964,860 | 0.22% |
News See All
STERIS plc (NYSE:STE) Q1 2026 Earnings Call Transcript
Operator: Good day, and welcome to the STERIS plc First Quarter 2026 Conference Call. [Operator Instructions] Please note, this event is being recorded.
Jefferies Initiates Coverage of Steris (STE) with ‘Hold’ Rating and $263 Price Target
Jefferies initiated coverage of Steris PLC (NYSE:STE) on May 28 with a 'Hold' rating and a $263 price target.
STERIS plc (NYSE:STE) Q4 2025 Earnings Call Transcript
Operator: Good morning, everyone, and welcome to the STERIS plc Fourth Quarter 2025 Conference Call. All participants will be in a listen-only mode.
10 Overlooked Dividend Stocks to Buy Now
In recent times, dividend investing—also known as equity income—has fallen out of favor. Once a widely followed and dependable strategy, it has gradually been overshadowed.
Jim Cramer’s Latest Lightning Round: 7 Stocks in Focus
On Thursday, Jim Cramer, the host of Mad Money, pointed out that the ongoing fears surrounding President Donald Trump's aggressive tariff policies continued to impact the market.
STERIS plc (STE) Slid on Cautious Health Care Sentiment
The London Company, an investment management company, released “The London Company Mid Cap Strategy” fourth quarter 2024 investor letter. A copy of the letter can be downloaded here.
Here’s Why STERIS plc (STE) Underperformed in Q4
Meridian Funds, managed by ArrowMark Partners, released its “Meridian Growth Fund” fourth quarter 2024 investor letter. A copy of the letter can be downloaded here.
STERIS plc (NYSE:STE) Q3 2025 Earnings Call Transcript
Operator: Good day, and welcome to the STERIS plc Third Quarter 2025 Conference Call. All participants will be in a listen-only mode.
STERIS plc (NYSE:STE) Q2 2025 Earnings Call Transcript
Operator: Good day, everybody, and welcome to the STERIS plc Second Quarter 2025 Earnings Call. [Operator Instructions] Please note, today's event is being recorded.